The relationship among human papilloma virus infection, survivin, and p53 gene in lung squamous carcinoma tissue

Saudi Medical Journal

Volumn 31, Issue 12, 2010, Pages 1331-1336

  Wang, Yue Hua ^a   Chen, De Jie ^a   Yi, Tie Nan ^a   Liu, Xiao Hong ^a  

^a Xiangfan Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ETHIDIUM BROMIDE; PROTEIN P53; SURVIVIN; VIRUS DNA;

ARTICLE; BENIGN TUMOR; CANCER TISSUE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA VIRUS INFECTION; EXON; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HOSPITAL; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SQUAMOUS CELL CARCINOMA; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; GENES, P53; HUMANS; LUNG NEOPLASMS; MICROTUBULE-ASSOCIATED PROTEINS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION;

EID: 79551639448     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Palozza P, Simone R, Mele MC. Interplay of carotenoids with cigarette smoking: implications in lung cancer. Curr Med Chem 2008; 15: 844-854.
2. Sampath J, Pelus LM. Alternative splice variants of survivin as potential targets in cancer. Curr Drug Discov Technol 2007; 4: 174-191.
3. Rezazadeh A, Laber DA, Ghim SJ, Jenson AB, Kloecker G. The role of human papilloma virus in lung cancer: a review of the evidence. Am J Med Sci 2009; 338: 64-67.
4. Shukla S, Bharti AC, Mahata S, Hussain S, Kumar R, Hedau S, et al. Infection of human papillomaviruses in cancers of different human organ sites. Indian J Med Res 2009; 130: 222-233.
5. Iwakawa R, Kohno T, Enari M, Kiyono T, Yokota J. Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma. Cancer Sci 2010; 101: 1891-1896.
6. Branica BV, Smojver-Jezek S, Juros Z, Grgić S, Srpak N, Mitrecić D, et al. Detection of human papillomaviruses type 16, 18 and 33 in bronchial aspirates of lung carcinoma patients by polymerase chain reaction: a study of 84 cases in Croatia. Coll Antropol 2010; 34: 159-162.
7. Syrjänen KJ. Epithelial lesions suggestive of a condylomatous origin found closely associated with invasive bronchial squamous cell carcinomas. Respiration 1980; 40: 150-160.
8. Joh J, Jenson AB, Moore GD, Rezazedeh A, Slone SP, Ghim SJ, et al. Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer. Exp Mol Pathol 2010 Aug 7. [Epub ahead of print]
9. Ciotti M, Giuliani L, Ambrogi V, Ronci C, Benedetto A, Mineo TC, et al. Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer. Oncol Rep 2006; 16: 183-189.
10. Wise-Draper TM, Wells SI. Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci 2008; 13: 1003-1017.
11. Pim D, Banks L. Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs low-risk human papillomaviruses. APMIS 2010; 118: 471-493.
12. Helt AM, Galloway DA. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 2003; 24: 159-169.
13. Borbély AA, Murvai M, Kónya J, Beck Z, Gergely L, Li F, et al. Effects of human papillomavirus type 16 oncoproteins on survivin gene expression. J Gen Virol 2006; 87: 287-294.
14. Branca M, Giorgi C, Santini D, Di Bonito L, Ciotti M, Costa S, et al. Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am J Clin Pathol 2005; 124: 113-121.
15. Srinivasan M, Taioli E, Ragin CC. Human papillomavirus type 16 and 18 in primary lung cancers: a meta-analysis. Carcinogenesis 2009; 30:1722-1728.
16. Yu Y, Yang A, Hu S, Yan H. Correlation of HPV-16/18 infection of human papillomavirus with lung squamous cell carcinomas in Western China. Oncol Rep 2009; 21: 1627-1632.
17. Rohrer J, Wuertz BR, Ondrey F. Cigarette smoke condensate induces nuclear factor kappa-b activity and proangiogenic growth factors in aerodigestive cells. Laryngoscope 2010; 120: 1609-1613.
18. Giuliani L, Favalli C, Syrjanen K, Ciotti M. Human papillomavirus infections in lung cancer. Detection of E6 and E7 transcripts and review of the literature. Anticancer Res 2007; 27: 2697-2704.
19. Chow J, Poon RY DNA damage and polyploidization. Adv ExpMed Biol 2010; 676: 57-71.
20. Cote ML. Study designs in genetic epidemiology. Methods Mol Biol 2009; 520: 247-257.
21. Maslon MM, Hupp TR. Drug discovery and mutant p53. Trends Cell Biol 2010; 20: 542-555.
22. Olivier M, Petitjean A, Marcel V, Pétré A, Mounawar M, Plymoth A, et al. Recent advances in p53 research: an interdisciplinary perspective. Cancer Gene Ther 2009;16: 1-12.
23. Wrzesień-Kuś A, Smolewski P, Sobczak-Pluta A, Wierzbowska A, Robak T. The inhibitor of apoptosis protein family and its antagonists in acute leukemias. Apoptosis 2004; 9: 705-715.
24. Liu GF, Zhao QG, Si L, Cao YG, Li GY, Wang LX. Effects of survivin interference RNA on non-small cell lung carcinoma. Clin Invest Med 2009; 32: E225.
25. Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S, et al. Human survivin is negatively regulated by wildtype p53 and participates in p53-dependent apoptotic pathway. Oncogene 2002; 21: 2613-2622.
26. Ghosh JC, Altieri DC. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells. Clin Cancer Res 2005; 11: 4580-4588.